252 related articles for article (PubMed ID: 32558473)
1. Reconsidering the Trade-offs of Prostate Cancer Screening.
Shoag JE; Nyame YA; Gulati R; Etzioni R; Hu JC
N Engl J Med; 2020 Jun; 382(25):2465-2468. PubMed ID: 32558473
[No Abstract] [Full Text] [Related]
2. Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guideline.
Tikkinen KAO; Dahm P; Lytvyn L; Heen AF; Vernooij RWM; Siemieniuk RAC; Wheeler R; Vaughan B; Fobuzi AC; Blanker MH; Junod N; Sommer J; Stirnemann J; Yoshimura M; Auer R; MacDonald H; Guyatt G; Vandvik PO; Agoritsas T
BMJ; 2018 Sep; 362():k3581. PubMed ID: 30185545
[No Abstract] [Full Text] [Related]
3. Prostate cancer: PSA update--no change yet.
Phillips R
Nat Rev Urol; 2014 Sep; 11(9):483. PubMed ID: 25134834
[No Abstract] [Full Text] [Related]
4. Surgery no better than observation for localized prostate cancer.
Printz C
Cancer; 2012 Nov; 118(22):5452-3. PubMed ID: 23129387
[No Abstract] [Full Text] [Related]
5. Validity and legacy of prostate-specific antigen (PSA) and PSA-based parameters and isoforms in the new millennium.
Djavan B
Eur Urol; 2010 Jun; 57(6):928-9. PubMed ID: 20304552
[No Abstract] [Full Text] [Related]
6. [Prostate cancer screening benefit very low, even after 13 years].
Blanker MH; Noordzij MA
Ned Tijdschr Geneeskd; 2014; 158():A8349. PubMed ID: 25492737
[TBL] [Abstract][Full Text] [Related]
7. Reconsidering Prostate Cancer Screening.
Schmidt C
J Natl Cancer Inst; 2017 Jan; 109(1):1-2. PubMed ID: 28104781
[No Abstract] [Full Text] [Related]
8. Updated results from the European Randomized Study of Prostate-Specific Antigen (PSA) Screening for Prostate Cancer: are Asian countries encouraged to promote PSA screening?
Sugimoto M; Kakehi Y
Asian J Androl; 2012 Jul; 14(4):522-4. PubMed ID: 22751444
[No Abstract] [Full Text] [Related]
9. Screening for prostate cancer: prostate-specific antigen testing is not effective.
Hitzeman N; Molina M
Am Fam Physician; 2011 Apr; 83(7):802-4. PubMed ID: 21524045
[No Abstract] [Full Text] [Related]
10. Prostate cancer screening and mortality: comparison of recent randomized controlled clinical trials.
Mian BM
Urol Oncol; 2010; 28(3):233-6. PubMed ID: 20097584
[No Abstract] [Full Text] [Related]
11. The phantom menace of prostate cancer screening.
Ghani KR; Trinh QD; Menon M
BJU Int; 2012 Feb; 109(3):324-6. PubMed ID: 22243666
[No Abstract] [Full Text] [Related]
12. Prostate cancer: modeling the outcomes of prostate cancer screening.
Loeb S; Carlsson S; Braithwaite RS
Nat Rev Urol; 2012 Mar; 9(4):183-5. PubMed ID: 22410678
[No Abstract] [Full Text] [Related]
13. Screening for prostate cancer.
Ruffin MT
J Fam Pract; 1999 Aug; 48(8):581-2. PubMed ID: 10496634
[No Abstract] [Full Text] [Related]
14. Reconsidering Prostate Cancer Mortality - The Future of PSA Screening.
Welch HG; Albertsen PC
N Engl J Med; 2020 Apr; 382(16):1557-1563. PubMed ID: 32294352
[No Abstract] [Full Text] [Related]
15. Prostate cancer: Prudent practice optimizes screening outcomes.
Auvinen A
Nat Rev Urol; 2016 Jul; 13(7):376-7. PubMed ID: 27215425
[No Abstract] [Full Text] [Related]
16. PSA Screening for Prostate Cancer.
Quaas J
Am Fam Physician; 2015 May; 91(9):Online. PubMed ID: 25955746
[No Abstract] [Full Text] [Related]
17. [Early detection of prostatic carcinoma: Is PSA screening suitable?].
Kaulen H
Dtsch Med Wochenschr; 2003 May; 128(18):977. PubMed ID: 12755136
[No Abstract] [Full Text] [Related]
18. [Early detection of cancer of the prostate. Pros and cons].
Hoesl CE; Altwein JE
MMW Fortschr Med; 2005 Apr; 147(14):32, 34-6. PubMed ID: 15887681
[TBL] [Abstract][Full Text] [Related]
19. Screening for prostate cancer: time to put all the data on the table.
Haines IE; Ablin RJ; Miklos GL
BMJ; 2016 May; 353():i2574. PubMed ID: 27226459
[No Abstract] [Full Text] [Related]
20. Screening for prostate cancer remains controversial.
Stark JR; Mucci L; Rothman KJ; Adami HO
BMJ; 2009 Sep; 339():b3601. PubMed ID: 19778971
[No Abstract] [Full Text] [Related]
[Next] [New Search]
